This inventor holds 3 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: University of Ghent. Active years: 2011-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gent Oost-Vlaanderen, BE (2011 - 2013)
- Kortrijk, BE (2017)
Company Filing History:
Years Active: 2011-2017
Title: Peter Delputte: Innovator in Virology
Introduction
Peter Delputte is a notable inventor based in Gent, Oost-Vlaanderen, Belgium. He has made significant contributions to the field of virology, particularly in the understanding and treatment of viruses affecting livestock. With three patents to his name, Delputte continues to pave the way for advancements in vaccine development and viral research.
Latest Patents
One of Peter Delputte's most recent inventions is related to the "Determination of Antigenicity of an Inactivated Virus." This patent aims to improve methods for assessing how viral inactivation procedures influence the antigenicity of viruses, especially those in the families Arteriviridae and Coronaviridae. The invention plays a crucial role in developing vaccines against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) by providing methods to screen for antiviral compounds and utilizing immunogenic viruses in vaccine manufacture.
Another significant patent is titled "Permissive Cells and Uses Thereof." This invention details methods for identifying and generating host cells that are permissive to diseases caused by viruses in the same families. It is particularly focused on PRRSV and includes methods for preparing viral cultures and their application in diagnostics and vaccine production.
Career Highlights
Peter Delputte is affiliated with Universiteit Gent, where he actively conducts research in virology. His work has had a substantial impact on the scientific community, helping to advance the understanding of viral behaviors and their implications for livestock health. Through his innovations, he has enhanced the methodologies used in vaccine research and development.
Collaborations
Throughout his career, Peter Delputte has collaborated with esteemed colleagues, including Hans Nauwynck and Hanne Van Gorp. These partnerships have facilitated the exchange of ideas and expertise, further contributing to advancements in their shared field of virology.
Conclusion
Peter Delputte exemplifies the spirit of innovation within the field of virology. His patented inventions demonstrate a commitment to enhancing vaccine development and understanding viral pathogenesis. As he continues his work at Universiteit Gent, Delputte’s contributions will undoubtedly shape future advancements in virology and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile